Newsfeeds Archive - Page 48 of 167

1 minute read

4D Molecular Therapeutics Q3 EPS $(0.79) Up From $(0.82) YoY

November 9, 6:22 PM

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.79) per share. This is a 3.66 percent increase over losses of $(0.82) per share from the same period last year.

FDMT

1 minute read

IO Biotech Q3 EPS $(0.56)

By Bill Haddad

November 9, 6:17 PM

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.56) per share.

IOBT

1 minute read

DICE Therapeutics Q3 EPS $(0.55) Up From $(2.15) YoY

By Bill Haddad

November 9, 6:15 PM

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.

DICE

1 minute read

PARTS iD Q3 EPS $(0.18) Down From $(0.10) YoY, Sales $79.90M Down From $102.60M YoY

By Bill Haddad

November 9, 6:04 PM

PARTS iD (AMEX:ID) reported quarterly losses of $(0.18) per share. This is a 80 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $79.90 million in sales this

1 minute read

Innoviva Q3 EPS $2.80 Up From $0.90 YoY, Sales $67.26M Down From $97.86M YoY

By Bill Haddad

November 9, 6:02 PM

Innoviva (NASDAQ:INVA) reported quarterly earnings of $2.80 per share. This is a 211.11 percent increase over earnings of $0.90 per share from the same period last year. The company reported $67.26 million in sales this

INVA

1 minute read

Vintage Wine Estates Q1 EPS $0.05 Beats $0.02 Estimate, Sales $77.90M Beat $67.51M Estimate

By Bill Haddad

November 9, 5:42 PM

Vintage Wine Estates (NASDAQ:VWE) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. This is unchanged from the same period last year. The company reported

VWE

1 minute read

Avinger Q3 Sales $2.30M Miss $2.80M Estimate

By Bill Haddad

November 9, 5:02 PM

Avinger (NASDAQ:AVGR) reported quarterly sales of $2.30 million which missed the analyst consensus estimate of $2.80 million by 17.86 percent. This is a 2.79 percent decrease over sales of $2.37 million the same period

AVGR

1 minute read

News

Athlon Acquisition Corp. Announces It Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination

By Bill Haddad

November 9, 8:38 AM

Athlon Acquisition Corp. (NASDAQ:SWET, SWETU and SWETW)) (the "Company") announced today that, due to its anticipated inability to consummate an initial business combination within the time period required by

SWET

1 minute read

Biohaven Pharmaceutical Q3 EPS $(1.75) Up From $(1.91) YoY

By Bill Haddad

November 9, 8:18 AM

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(1.75) per share. This is a 8.38 percent increase over losses of $(1.91) per share from the same period last year.

BHVN

1 minute read

OceanFirst Financial Corp. And Partners Bancorp Announce Mutual Termination Of Merger Agreement

By Bill Haddad

November 9, 8:15 AM

OceanFirst Financial Corp. (NASDAQ:OCFC) ("OceanFirst"), the holding company for OceanFirst Bank N.A., and Partners Bancorp (NASDAQ:PTRS) ("Partners"), the parent company of The Bank of Delmarva (and

OCFC